logo

For the Inventor, By the Inventor

Ledyard, CT, United States of America

Kishor A Desai

USPTO Granted Patents = 9

Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 40(Granted Patents)


Company Filing History:

goldMedal9 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 1992-2007

Loading Chart...
9 patents (USPTO):Explore Patents
1. 7220753 - 2,7-substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives as ligands for serotonin receptors (2007-05-22),
2. 6525196 - 5HT1 antagonists for antidepressant therapy (2003-02-25),
3. 6231833 - 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors (2001-05-15),
4. 6166020 - Aryl and heteroaryl alkoxynaphthalene derivatives (2000-12-26),
5. 5852031 - 2,7-substituted octahydro-1H-pyrido�1,2-a!pyrazine derivatives (1998-12-22),
6. 5731307 - Neuroleptic 2,7-disubtituted perhydro-1h-pyrido�1, 2-A!pyrazines (1998-03-24),
7. 5565453 - Neuroleptic 2-substituted perhydro-1-h-pyrido[1,2-a]pyrazines (1996-10-15),
8. 5157034 - Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines (1992-10-20),
9. 5122525 - Bis-aza-bicyclic anxiolytic agents (1992-06-16),

Certainly! Here is an article about inventor Kishor A. Desai based on the provided data:

Title: Unveiling the Innovative Journey of Kishor A. Desai

Introduction:

In the realm of inventiveness lies the remarkable journey of Kishor A. Desai, an esteemed inventor hailing from Ledyard, CT (US). With a remarkable portfolio of 9 patents under his belt, Mr. Desai has made significant contributions to the world of science and technology.

Latest Patents:

Among his latest patents is the groundbreaking invention of 2,7-substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives as ligands for serotonin receptors. These substituted pyrido[1,2-a]pyrazines serve as essential ligands for dopamine receptor subtypes and serotonin (5HT) in the body, paving the way for innovative treatment methods for disorders of the dopamine and serotonin systems. Another notable patent includes 5HT1 antagonists for antidepressant therapy, showcasing Mr. Desai's commitment to enhancing mental health treatments.

Career Highlights:

Kishor A. Desai's invaluable expertise is honed at Pfizer Corporation, where he channels his passion for innovation into groundbreaking research and development. His tenure at Pfizer Corporation has been marked by a relentless pursuit of excellence in the pharmaceutical industry, revolutionizing the landscape of medical treatments.

Collaborations:

In his quest for innovation, Kishor A. Desai has collaborated with esteemed colleagues such as Gene M. Bright and Mark Allen Sanner. Together, they have synergized their talents to drive forward groundbreaking research projects and patents that have redefined the boundaries of modern medicine.

Conclusion:

In conclusion, Kishor A. Desai stands as a shining example of innovation and ingenuity in the field of inventiveness. His commitment to pushing the boundaries of science and technology, as evidenced by his myriad patents and collaborations, cements his legacy as a trailblazer in the realm of pharmaceutical innovation.

I hope this article provides insight into the remarkable journey of inventor Kishor A. Desai.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…